Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why NovoCure Stock Soared 32% in July

TheMotleyFool

0 0

Shares of NovoCure (NASDAQ: NVCR), which makes a device for treating cancerous solid tumors with electric fields, rocketed 31.6% higher in July, according to data from S&P Global Market Intelligence.

For context, the S&P 500 returned 1.4% last month.

NovoCure stock has been on a tear in 2019, with shares up 157% this year through Aug. 2, versus the broader market's 18.3% return.

Quelle Fool.com

Like: 0

NVCR

Share